News|Articles|March 18, 2025
Differentiating oxidative metabolite isomers of the molecular glue, mezigdomide, using electron-activated dissociation (EAD)
Author(s)SCIEX
Here we discuss a software-assisted drug metabolite identification and characterization workflow. The approach allows scientists to have increased confidence in the process.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Industry Outlook 2026: Trends Transitioning from 2025 into 2026
2
Amgen Acquires UK Biotech Dark Blue Therapeutics
3
Multi-Compendial Compliance for Pharmaceutical Excipients–Part 2: A Detailed Assessment for Specification Equivalence
4
Navigating Financial and Opportunity Risks in Accelerated Drug Launches
5